85.38
price down icon2.05%   -1.79
after-market 시간 외 거래: 86.20 0.82 +0.96%
loading

Incyte Corp 주식(INCY)의 최신 뉴스

pulisher
11:37 AM

Incyte Faces Revenue Squeeze As Jakafi Patent Winds Down - Finimize

11:37 AM
pulisher
08:00 AM

Incyte to Report Third Quarter Financial Results - Business Wire

08:00 AM
pulisher
03:49 AM

Incyte stock rating downgraded to Perform by Oppenheimer - Investing.com

03:49 AM
pulisher
Oct 07, 2025

Will Incyte (INCY) Beat Estimates Again in Its Next Earnings Report? - Yahoo Finance

Oct 07, 2025
pulisher
Oct 06, 2025

Incyte Corporation (INCY) Appoints New Principal Financial Officer - GuruFocus

Oct 06, 2025
pulisher
Oct 06, 2025

Is Incyte Corporation (ICY) stock a defensive play amid uncertaintyTrade Signal Summary & Free Fast Gain Swing Trade Alerts - newser.com

Oct 06, 2025
pulisher
Oct 06, 2025

How to use Fibonacci retracement on Incyte CorporationPortfolio Update Summary & Target Return Focused Stock Picks - newser.com

Oct 06, 2025
pulisher
Oct 06, 2025

Grimes & Company Inc. Has $12.26 Million Position in Incyte Corporation $INCY - MarketBeat

Oct 06, 2025
pulisher
Oct 06, 2025

Price action breakdown for Incyte CorporationJuly 2025 PostEarnings & Step-by-Step Swing Trade Plans - newser.com

Oct 06, 2025
pulisher
Oct 05, 2025

Legacy Trust Cuts Holdings in Incyte Corporation $INCY - MarketBeat

Oct 05, 2025
pulisher
Oct 05, 2025

Published on: 2025-10-05 05:30:49 - newser.com

Oct 05, 2025
pulisher
Oct 05, 2025

Why Incyte Corporation (ICY) stock is favored by hedge funds2025 Stock Rankings & Community Consensus Stock Picks - newser.com

Oct 05, 2025
pulisher
Oct 05, 2025

How Incyte Corporation (ICY) stock reacts to stronger dollar2025 Price Targets & Free Long-Term Investment Growth Plans - newser.com

Oct 05, 2025
pulisher
Oct 05, 2025

Is Incyte Corporation stock a safe buy before earningsVolume Spike & Short-Term Trading Alerts - newser.com

Oct 05, 2025
pulisher
Oct 05, 2025

Institutional scanner results for Incyte Corporation2025 Growth vs Value & High Accuracy Buy Signal Tips - newser.com

Oct 05, 2025
pulisher
Oct 04, 2025

Incyte Grants Equity Awards to New Chief Strategy Officer David Gardner - MyChesCo

Oct 04, 2025
pulisher
Oct 04, 2025

Incyte Appoints Thomas Tray as Financial Officer - The Globe and Mail

Oct 04, 2025
pulisher
Oct 04, 2025

Incyte (NASDAQ:INCY) Raised to "Strong-Buy" at Wall Street Zen - MarketBeat

Oct 04, 2025
pulisher
Oct 03, 2025

Will Incyte's (INCY) New Strategy Team and CALR Antibody Hopes Reshape Its Long-Term Story? - simplywall.st

Oct 03, 2025
pulisher
Oct 03, 2025

Incyte appoints Thomas Tray as principal financial officer - StreetInsider

Oct 03, 2025
pulisher
Oct 03, 2025

Incyte (INCY) Is Up 5.7% After FDA Pediatric Opzelura Approval and Leadership Updates Has the Bull Case Changed? - simplywall.st

Oct 03, 2025
pulisher
Oct 03, 2025

Incyte Names Dave Gardner Chief Strategy Officer Amid Leadership Transition - MyChesCo

Oct 03, 2025
pulisher
Oct 03, 2025

Will Incyte Corporation stock outperform value stocksWeekly Gains Report & Community Consensus Trade Alerts - newser.com

Oct 03, 2025
pulisher
Oct 03, 2025

Backtesting results for Incyte Corporation trading strategiesMarket Risk Summary & Community Consensus Picks - newser.com

Oct 03, 2025
pulisher
Oct 02, 2025

Incyte Corporation stock hits 52-week high at 88.19 USD By Investing.com - Investing.com Australia

Oct 02, 2025
pulisher
Oct 02, 2025

FDA Expands Approval of Incyte’s Opzelura to Treat Pediatric Atopic Dermatitis - MSN

Oct 02, 2025
pulisher
Oct 02, 2025

Incyte Corporation stock hits 52-week high at 88.19 USD - Investing.com

Oct 02, 2025
pulisher
Oct 02, 2025

Robeco Institutional Asset Management B.V. Has $162.51 Million Stock Position in Incyte Corporation $INCY - MarketBeat

Oct 02, 2025
pulisher
Oct 02, 2025

Incyte (INCY) Price Target Lifted on CALR Antibody Program Optimism - Yahoo Finance

Oct 02, 2025
pulisher
Oct 02, 2025

2 Reasons to Like INCY and 1 to Stay Skeptical - The Globe and Mail

Oct 02, 2025
pulisher
Oct 01, 2025

Lbp Am Sa Has $12.17 Million Stock Position in Incyte Corporation $INCY - MarketBeat

Oct 01, 2025
pulisher
Sep 30, 2025

Poinciana Advisors Group LLC Makes New Investment in Incyte Corporation $INCY - MarketBeat

Sep 30, 2025
pulisher
Sep 29, 2025

Will Incyte Corporation (ICY) stock see insider accumulationQuarterly Profit Report & AI Enhanced Market Trend Forecasts - newser.com

Sep 29, 2025
pulisher
Sep 28, 2025

Patton Albertson Miller Group LLC Acquires 5,497 Shares of Incyte Corporation $INCY - MarketBeat

Sep 28, 2025
pulisher
Sep 28, 2025

Patton Fund Management Inc. Takes $254,000 Position in Incyte Corporation $INCY - MarketBeat

Sep 28, 2025
pulisher
Sep 28, 2025

China Medical System (867.HK; 8A8.SG) Positive Results from China Phase 3 Clinical Trial of Innovative Drug Ruxolitinib Cream with AD Indication - GlobeNewswire Inc.

Sep 28, 2025
pulisher
Sep 27, 2025

Candlestick signals on Incyte Corporation stock todayMarket Performance Recap & Breakout Confirmation Alerts - newser.com

Sep 27, 2025
pulisher
Sep 27, 2025

Incyte (INCY) Advances Clinical Trials for Povorcitinib Across Multiple Conditions - Yahoo Finance

Sep 27, 2025
pulisher
Sep 25, 2025

INCY's Q4 Earnings Miss Mark, Revenues Beat on Higher Product Sales - MSN

Sep 25, 2025
pulisher
Sep 25, 2025

Jim Cramer Calls Incyte “Way Too Cheap” - Yahoo Finance

Sep 25, 2025
pulisher
Sep 25, 2025

Ruffer LLP Sells 9,988 Shares of Incyte Corporation $INCY - MarketBeat

Sep 25, 2025
pulisher
Sep 25, 2025

Incyte (INCY) Gets a Hold from RBC Capital - The Globe and Mail

Sep 25, 2025
pulisher
Sep 24, 2025

Incyte Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)September 24, 2025 - biospace.com

Sep 24, 2025
pulisher
Sep 24, 2025

RBC Capital Raises Price Target for Incyte (INCY) to USD 81 | IN - GuruFocus

Sep 24, 2025
pulisher
Sep 24, 2025

Incyte stock price target raised to $81 from $72 at RBC Capital - Investing.com

Sep 24, 2025
pulisher
Sep 24, 2025

Guggenheim Reaffirms "Neutral" Rating for Incyte (NASDAQ:INCY) - MarketBeat

Sep 24, 2025
pulisher
Sep 24, 2025

Incyte’s Povorcitinib Shows Sustained Efficacy in Phase 3 HS Trial, Supports 2025/2026 Regulatory Submissions - Insider Monkey

Sep 24, 2025
pulisher
Sep 23, 2025

Mn Services Vermogensbeheer B.V. Sells 6,600 Shares of Incyte Corporation $INCY - MarketBeat

Sep 23, 2025
pulisher
Sep 23, 2025

Is Incyte Stock Outperforming The S&P 500? - Barchart.com

Sep 23, 2025
pulisher
Sep 23, 2025

Incyte Corporation (NASDAQ:INCY) Short Interest Down 21.8% in August - MarketBeat

Sep 23, 2025
pulisher
Sep 23, 2025

Incyte Corporation $INCY Stake Lowered by Diversified Trust Co - MarketBeat

Sep 23, 2025
pulisher
Sep 23, 2025

Incyte Announces the Appointment of Dave Gardner as Executive Vice President and Chief Strategy Officer - BioSpace

Sep 23, 2025
pulisher
Sep 23, 2025

Analysts Set Incyte Corporation (NASDAQ:INCY) Target Price at $82.53 - MarketBeat

Sep 23, 2025
pulisher
Sep 22, 2025

Sovran Advisors LLC Sells 12,174 Shares of Incyte Corporation $INCY - MarketBeat

Sep 22, 2025
pulisher
Sep 22, 2025

Is Incyte Corporation a candidate for recovery playJuly 2025 Levels & Proven Capital Preservation Tips - newser.com

Sep 22, 2025
pulisher
Sep 22, 2025

Incyte (NASDAQ:INCY) Price Target Raised to $115.00 at Stifel Nicolaus - MarketBeat

Sep 22, 2025
pulisher
Sep 22, 2025

Stifel Raises Price Target for Incyte (INCY) to $115 While Maint - GuruFocus

Sep 22, 2025
$23.34
price up icon 4.71%
$32.74
price up icon 0.31%
$106.28
price up icon 0.21%
$161.81
price down icon 0.31%
biotechnology ONC
$351.09
price up icon 2.77%
자본화:     |  볼륨(24시간):